SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 344 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $8,000 | -97.5% | 50 | -99.0% | 0.01% | -98.6% |
| Q3 2016 | $315,000 | +46.5% | 5,132 | -7.9% | 0.36% | +37.0% |
| Q4 2015 | $215,000 | 0.0% | 5,575 | -16.9% | 0.26% | +3.1% |
| Q3 2015 | $215,000 | -64.0% | 6,707 | -65.8% | 0.26% | -63.8% |
| Q2 2015 | $597,000 | +0.2% | 19,607 | -52.4% | 0.71% | +4.3% |
| Q4 2014 | $596,000 | -29.1% | 41,175 | +3.3% | 0.68% | -30.2% |
| Q3 2014 | $841,000 | +27.8% | 39,875 | +80.6% | 0.98% | +35.8% |
| Q2 2014 | $658,000 | -15.0% | 22,075 | -31.5% | 0.72% | -21.4% |
| Q1 2014 | $774,000 | 0.0% | 32,215 | -15.2% | 0.91% | -6.2% |
| Q4 2013 | $774,000 | – | 38,000 | – | 0.97% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |